1-methyl-4-phenylpyridinium has been researched along with Nervous System Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beal, MF; Finklestein, S; Henshaw, R; Kirschner, PB; Schulz, JB; Trubetskoy, V; Weise, J | 1 |
| Beal, MF; Henshaw, DR; Matthews, RT; Schulz, JB | 1 |
| Ali, SF; Desai, VG; Feuers, RJ; Hart, RW | 1 |
| Cano, J; Machado, A; Merino, M; Vizuete, ML | 1 |
| Giovanni, A; Manzino, L; Nicklas, WJ; Sonsalla, PK; Zeevalk, GD | 1 |
| Booth, RG; Castagnoli, N; Johnson, EA; Rollema, H; Trevor, AJ; Wu, EY | 1 |
| Booth, RG; Castagnoli, N; Rollema, H | 1 |
7 other study(ies) available for 1-methyl-4-phenylpyridinium and Nervous System Diseases
| Article | Year |
|---|---|
Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Cell Death; Excitatory Amino Acids; Fibroblast Growth Factor 2; Hypoxia; Male; Malonates; N-Methylaspartate; Nervous System Diseases; Neurons; Rats; Rats, Sprague-Dawley | 1995 |
Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Anticonvulsants; Coenzymes; Cyclic N-Oxides; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Free Radicals; Lamotrigine; Male; Malonates; Memantine; Mitochondria; Nervous System Diseases; Neuroprotective Agents; Neurotoxins; Niacinamide; Nitro Compounds; Nitrogen Oxides; Propionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Spin Labels; Thallium; Triazines; Ubiquinone | 1996 |
MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Brain; Dopamine Agents; Electron Transport; Electron Transport Complex IV; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Nervous System Diseases | 1996 |
In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Catecholamines; Cytochrome P-450 Enzyme System; Dopamine; Dopamine Agents; Hypnotics and Sedatives; Immunohistochemistry; Male; Neostriatum; Nervous System Diseases; Phenobarbital; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 1997 |
MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Dizocilpine Maleate; Dopamine; Male; Mice; Mice, Inbred Strains; Nervous System Diseases; Rats; Rats, Inbred Strains; Substantia Nigra | 1992 |
1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases; Neurons; Neurotoxins; Receptors, Dopamine; Synaptosomes | 1989 |
In vivo dopaminergic neurotoxicity of the 2-beta-methylcarbolinium ion, a potential endogenous MPP+ analog.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Carbolines; Corpus Striatum; Dialysis; Dopamine; Male; Nervous System Diseases; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1988 |